| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | 0.32 | 0.01 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.02 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.02 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | 0.29 | 0.02 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.075 | 0.02 |